Viewing data from:

EPINASTINE HYDROCHLORIDE

ANDA

EPINASTINE HYDROCHLORIDE | A090951 | SOMERSET THERAPEUTICS LLC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 1 NDC

Highest NADAC/Unit

$14.76

per ml

Lowest NADAC/Unit

$14.76

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
70069000801EPINASTINE HCL 0.05% EYE DROPS	$14.76	ML	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs1 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGEPINASTINE HYDROCHLORIDE

DMF 150032000

ICROM SRLEPINASTINE HYDROCHLORIDE

DMF 218302008

TRIFARMA SPAEPINASTINE HYDROCHLORIDE

DMF 218512008

SUN PHARMACEUTICAL INDUSTRIES LTDEPINASTINE HYDROCHLORIDE

DMF 228542009

WUHAN CALMLAND PHARMACEUTICALS CO LTDEPINASTINE HYDROCHLORIDE

DMF 402562024

EXCELLA GMBH AND CO KGInactiveEPINASTINE HYDROCHLORIDE

DMF 209932007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 0.05%

0 patents0 exclusivities▴

SOLUTION/DROPS;OPHTHALMIC | Approved: Oct 31, 2011

No patent or exclusivity listings for this strength.